Crossmark

Common polygenic risk for autism spectrum disorder (ASD) is associated with cognitive ability in the general population

Crossref DOI link: https://doi.org/10.1038/mp.2015.12

Published Online: 2015-03-10

Published Print: 2016-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Clarke, T-K

Lupton, M K

Fernandez-Pujals, A M

Starr, J

Davies, G

Cox, S

Pattie, A

Liewald, D C

Hall, L S

MacIntyre, D J

Smith, B H

Hocking, L J

Padmanabhan, S

Thomson, P A

Hayward, C

Hansell, N K

Montgomery, G W

Medland, S E

Martin, N G

Wright, M J

Porteous, D J

Deary, I J

McIntosh, A M
License Information

Text and Data Mining valid from 2015-03-10
More Information

Article History

Received: 23 April 2014

Revised: 25 November 2014

Accepted: 19 December 2014

First Online: 10 March 2015

Competing interests

: AMM has received financial support from Pfizer (formerly Wyeth), Janssen and Lilly. AMM has done consultancy work for Roche Pharmaceuticals. The other authors declare no conflict of interest.